In a sharp break from more than three decades of U.S. vaccine policy, a CDC advisory panel voted Friday to stop recommending that every newborn receive a hepatitis B vaccine at birth. Members of the ...

Add Yahoo as a preferred source to see more of our stories on Google. The Centers for Disease Control and Prevention's vaccine advisory panel is holding two days of meetings about childhood vaccine ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr.'s influential vaccine advisory panel has voted to no longer universally ...

Public health, explained: Sign up to receive Healthbeat’s free national newsletter here. The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine ...

On Friday, the Centers for Disease Control and Prevention’s vaccine panel voted eight to three in favor of abandoning the universal recommendation of vaccinating newborns for hepatitis B, a dramatic ...

U.S. federal guidelines currently recommend that all newborns get a dose of a hepatitis B vaccine, but a CDC advisory committee has voted to change that approach. Here’s what’s at stake. Today a ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Elaine’s stories explore the boom in new obesity treatments, new drug ...

As U.S. Health Secretary Robert F. Kennedy Jr.'s vaccine advisory panel gears up to debate hepatitis B immunization for infants this week, health experts say that delaying the shot usually given at ...

Health and Human Services Secretary Robert F. Kennedy Jr.'s influential vaccine advisory panel has voted to no longer universally recommend the first dose of the hepatitis B vaccine for newborns ...

Update: The CDC's vaccine advisory panel voted Friday to stop recommending the birth dose of the hepatitis B vaccine for babies whose mothers test negative for the virus. Read the latest here. Our ...

The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. This comes despite a failed attempt to do so at the most ...